NEW HOPE, Pa.--(BUSINESS WIRE)--Protalex, Inc. (OTCBB: PRTX) announced today the appointment of Edward W. Bernton, MD, to the position of Medical Director. Dr. Bernton has over 20 years experience in medical research and therapeutic product development specializing in Pharmacology, Clinical Immunology, Immunotoxicology, and Experimental Medicine. His broad experience includes planning and execution of numerous Investigational New Drug (IND) applications as well as authoring protocols for over 30 Phase I & II studies. Prior to positions with Quintiles, Inc., Analytica Therapeutics, and Parexel International, Dr. Bernton spent 11 years in laboratory and clinical research at Walter Reed Army Institute of Research.
